Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis

BACKGROUND: Radiofrequency ablation (RFA) destroys tumors through hyperthermic injury, which induces the release of immunogenic intracellular substrates and damages associated molecular patterns (DAMPs) to evoke a systemic immune response, but its therapeutic effect is limited. This study aimed to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhou, Hong, Baojian, Chen, Jianzhong, Tang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201999/
https://www.ncbi.nlm.nih.gov/pubmed/35719978
http://dx.doi.org/10.3389/fonc.2022.891724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201999/
https://www.ncbi.nlm.nih.gov/pubmed/35719978
http://dx.doi.org/10.3389/fonc.2022.891724

Ejemplares similares